Cellecta New Products Posted to GenomeWeb: Standard BioTools, Cellecta, Codex DNA New products and services posted to GenomeWeb for the week of Oct. 3, 2022. MilliporeSigma Licenses CRISPR-Cas9 Technology to Cellecta Cellecta said it will use MilliporeSigma's technology to offer its customers CRISPR-mediated targeted gene knock-in services. New Products Posted to GenomeWeb: Bio-Rad, One Codex, Cellecta, More New Products Posted to GenomeWeb: Cellecta, Indigo, Expedeon, More New Products Posted to GenomeWeb: Pacific Biosciences, Oxford Nanopore, Cellecta, More Nov 10, 2017 Cellecta Licenses CRISPR IP From ERS Genomics Jan 26, 2017 Cellecta Awarded Phase II SBIR Grant to Finalize Development of CRISPR Screening Platform Nov 30, 2016 Cellecta Launches Targeted Expression Profiling Service for 19K Human Genes Premium Apr 15, 2016 Cellecta Finds Changes to Guide RNA Sequences Improve Genome-Wide Knockout Screens Premium Jul 17, 2015 Cellecta Wins NIH SBIR Grant to Develop Guide RNA Library for CRISPR Genome Editing Dec 9, 2010 Products & Services: Dec 9, 2010 Premium Oct 1, 2010 Cellecta Lands $1.8M SBIR Grant Sep 9, 2010 Products & Services: Sep 9, 2010 Premium Aug 20, 2010 Ariadne and Cellecta to Merge Pathway Analysis and siRNA Screens for Prostate Cancer Database Premium Aug 16, 2010 Collaboration to Develop Knowledgebase of Pathways for Prostate Cancer Breaking News Ceres Nanosciences Wins $1.4M in NIH RADx Funding for Additional Wastewater Epidemiology Centers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer GenomeWeb Top 40 up 8 Percent in November, Outpacing Broader Market Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay ERS Genomics Licenses CRISPR-Cas9 IP to Cosmo Bio The Scan New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability. Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances. New mRNA Vaccines Offer Hope for Fighting Malaria A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines. Unique Germline Variants Found Among Black Prostate Cancer Patients Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.